|Over a week ago|
Roth Capital upgrades Himax to Buy on improving outlook for core business » 14:2802/1302/13/20
Roth Capital analyst Suji…
Roth Capital analyst Suji Desilva upgraded Himax to Buy from Neutral after the company reported Q4 revenue growth that illustrated broad display driver growth across both large and small panel segments. Himax also issued guidance that was well ahead of consensus and reflected a broad ramp across multiple key segments, said Desilva. The analyst raised his price target on Himax shares to $7 from $4, citing the improved prospects and visibility across its core segments.
Himax upgraded to Buy from Neutral at Roth Capital » 14:2102/1302/13/20
Roth Capital analyst Suji…
Roth Capital analyst Suji Desilva upgraded Himax to Buy from Neutral.
Himax price target raised to $6.50 from $5.00 at Lake Street » 13:5202/1302/13/20
Lake Street analyst…
Lake Street analyst Jaeson Schmidt raised his price target on Himax shares to $6.50 from $5.00 following the company's Q4 report, telling investors he is "hard pressed to find anything to pick at" given that revenue, gross margins and earnings guidance all beat consensus estimates. The guidance "is even more impressive" since management said they took an approximate 10% haircut on their outlook to reflect the uncertainty of the coronavirus, according to Schmidt, who keeps a Buy rating on Himax shares.
Himax sees strength in Q1 accelerating into Q2, rest of FY20 » 05:5902/1302/13/20
"When Himax hosted…
"When Himax hosted its third quarter earnings call this past November, the company was facing trends in the marketplace that created headwinds for the company. Specifically, at that time the company's performance and forecast reflected challenges Himax faced in its smartphone TDDI business. This was exacerbated by an oversupply of capacity in the LCD industry that negatively impacted its display driver IC sales and margin. As a result, the company's overall sales and outlook were weak. Since that time, the company has started to see major turnaround in literally all aspects of its businesses and is seeing strength across all major product lines for the first quarter. The strength the company is seeing in Q1 is expected to accelerate into Q2 and throughout the rest of 2020."
Himax reports Q4 EPS 9c, consensus (2c) » 05:5802/1302/13/20
Reports Q4 revenue…
Reports Q4 revenue $174.9M, consensus $166.17M. "We pre-announced preliminary key financial results for the fourth quarter on January 7, 2020 as the revenues, gross margin and EPS of the quarter all exceeded our guidance issued on November 7, 2019. Revenues and gross margin were in line with the pre-announced results while EPS were at the high end of the range. When we hosted our third quarter earnings call this past November, we were facing trends in the marketplace that created headwinds for us. Specifically, at that time our performance and forecast reflected challenges we faced in our smartphone TDDI business. This was exacerbated by an oversupply of panel capacity in the LCD industry that negatively impacted our display driver IC sales and margin. As a result, our overall sales and outlook were weak. Since that time, we have started to see major turnaround in literally all aspects of our businesses," said Jordan Wu, President and CEO of Himax.
Himax upgraded to Buy from Hold at Lake Street » 07:5301/3101/31/20
Lake Street analyst…
Lake Street analyst Jaeson Schmidt upgraded Himax Technologies to Buy from Hold with a price target of $5, up from $2.50. The analyst believes Himax has seen growing momentum across numerous product lines over the past couple of months. He has increasing confidence the company can return to "solid, double-digit" growth this year and show improving profitability as the year progresses. Himax's ability to provide "solid" Q1 guidance and positive commentary on the expanding design win pipeline for the year "should be enough evidence the growth story is back on track," Schmidt contends.
|Over a month ago|
Fly Intel: Wall Street's top stories for Tuesday » 16:4001/0701/07/20
APA, TOT, TMUS, S, BA, SONO, GOOG, GOOGL, APLS, HIMX, CLVS, CRNC
The Dow, S&P 500 and…
Fly Intel: Wall Street's top stories at midday » 12:1601/0701/07/20
APA, TOT, TMUS, S, APLS, HIMX, CLVS, CRNC
The Dow and S&P 500…
Fly Intel: Pre-market Movers » 09:1201/0701/07/20
APLS, TSLA, HIMX, ANGO, KMDA, CRWD, ARE
HIGHER: Apellis Pharmaceuticals (APLS), up 45% after announcing that pegcetacoplan met the study's primary efficacy endpoint, demonstrating superiority to eculizumab with a statistically significant improvement in adjusted means of 3.8 g/dL of hemoglobin at week 16... Tesla (TSLA), up 1% after Reuters reports the company has started work on building Model Y SUVs at its Shanghai plant. CEO Elon Musk said, "Ultimately Tesla Model Y will have more demand than probably all the other cars of Tesla combined."... Himax (HIMX), up 8% after reporting preliminary Q4 earnings... Microchip (MCHP), up 4% after announcing its revised Q3 revenue outlook. UP AFTER EARNINGS: AngioDynamics (ANGO), up 1%. LOWER: Alexion (ALXN), down 2% after Apellis reported top-line data showing that pegcetacoplan demonstrated superiority to its Soliris, or eculizumab... Kamada (KMDA), down 4% after announcing Q4 and FY19 revenue expectations below consensus. Also, the company's CEO Amir London said "...while the planned transition of GLASSIA manufacturing to Takeda is expected to decrease our revenue and profitability during the years 2021 and 2022, our continued business development efforts are expected to result in resumed revenue and profitability growth beginning in 2023." ... Crowdstrike (CRWD), down 1% after a 5M share block trade priced at $53.80... Alexandria Real Estate (ARE), down 3% after its 6M share secondary offering priced at $155.00.
Himax reports Q4 preliminary non-IFRS earnings per diluted ADS 0.6c-0.9c » 06:3301/0701/07/20
Q4 EPS consensus (4c).…
Q4 EPS consensus (4c). Reports preliminary Q4 revenue $174.9M, consensus $162.7M. Reports preliminary Q4 gross margin 20.6% versus the guidance of a slight increase from the third quarter's 19.5%.